Home › Parkinson's Disease › Connecticut › East Norwalk
Parkinson's Disease clinical trials in East Norwalk, CT
3 studies for Parkinson's Disease are looking for participants at sites in and around East Norwalk (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
RecruitingPhase 3
- Parkinson's Research Centers of America - Long Island, Commack · 19 mi away
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
RecruitingObservational study
- Parkinson's Disease and Movement Disorders Center - Long Island, Commack · 19 mi away
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
RecruitingPhase 4
- Parkinson's Research Centers of America - Long Island, Commack · 19 mi away
About Parkinson's Disease
Parkinson's disease (PD) is a movement disorder. It causes tremors, stiffness, and slow movement. It gets worse over time. Learn what can help.
More about Parkinson's Disease on MedlinePlus
Parkinson's Disease trials in other cities
- New York City, NY23 studies
- Boston, MA19 studies
- Cleveland, OH18 studies
- Minneapolis, MN17 studies
- Nashville, TN15 studies
- Philadelphia, PA14 studies
- San Francisco, CA14 studies
- New Haven, CT14 studies
- Charleston, SC13 studies
- Farmington Hills, MI13 studies
- Chicago, IL13 studies
- Miami, FL13 studies
Other studies in East Norwalk
- Breast Cancer35 studies
- Non-Small Cell Lung Cancer18 studies
- Prostate Cancer16 studies
- Acute Myeloid Leukemia14 studies
- Multiple Myeloma13 studies
- Endometrial Cancer12 studies
- Bladder Cancer10 studies
- Lung Cancer10 studies
- Ovarian Cancer10 studies
- Cancer (all types)10 studies
- Lymphoma8 studies
- Colorectal Cancer8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.